Lem Moye
Overview
Explore the profile of Lem Moye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
432
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Perin E, Murphy M, March K, Bolli R, Loughran J, Yang P, et al.
Circulation
. 2017 Feb;
135(15):1417-1428.
PMID: 28209728
Background: Atherosclerotic peripheral artery disease affects 8% to 12% of Americans >65 years of age and is associated with a major decline in functional status, increased myocardial infarction and stroke...
12.
Ambale Venkatesh B, Nauffal V, Noda C, Fujii T, Yang P, Bettencourt J, et al.
Am Heart J
. 2016 Dec;
183:24-34.
PMID: 27979038
Background: Peripheral artery disease (PAD) is important to public health as a major contributor to cardiovascular morbidity and mortality. Recent developments in magnetic resonance imaging (MRI) techniques permit improved assessment...
13.
Contreras A, Orozco A, Resende M, Schutt R, Traverse J, Henry T, et al.
Basic Res Cardiol
. 2016 Nov;
112(1):3.
PMID: 27882430
Autologous bone marrow mononuclear cell (BM-MNC) therapy for patients with ST-segment elevation myocardial infarction (STEMI) has produced inconsistent results, possibly due to BM-MNC product heterogeneity. Patient-specific cardiovascular risk factors (CRFs)...
14.
Bhatnagar A, Bolli R, Johnstone B, Traverse J, Henry T, Pepine C, et al.
Am Heart J
. 2016 Sep;
179:142-50.
PMID: 27595689
Background: Although several preclinical studies have shown that bone marrow cell (BMC) transplantation promotes cardiac recovery after myocardial infarction, clinical trials with unfractionated bone marrow have shown variable improvements in...
15.
Park K, Lai D, Handberg E, Moye L, Perin E, Pepine C, et al.
Tex Heart Inst J
. 2016 Aug;
43(4):291-6.
PMID: 27547135
We know that endocardial mapping reports left ventricular electrical activity (voltage) and that these data can predict outcomes in patients undergoing traditional revascularization. Because the mapping data from experimental models...
16.
Henry T, Moye L, Traverse J
Circ Res
. 2016 Jul;
119(3):404-6.
PMID: 27458193
No abstract available.
17.
Moye L
Circ Res
. 2016 Feb;
118(3):439-53.
PMID: 26846639
Rationale: Biostatistics continues to play an essential role in contemporary cardiovascular investigations, but successful implementation of biostatistical methods can be complex. Objective: To present the rationale behind statistical applications and...
18.
Golpanian S, Schulman I, Ebert R, Heldman A, DiFede D, Yang P, et al.
Stem Cells Transl Med
. 2015 Dec;
5(2):186-91.
PMID: 26683870
An important stage in the development of any new therapeutic agent is establishment of the optimal dosage and route of administration. This can be particularly challenging when the treatment is...
19.
Taylor D, Perin E, Willerson J, Zierold C, Resende M, Carlson M, et al.
Cell Transplant
. 2015 Nov;
25(9):1675-1687.
PMID: 26590374
In the current study, we sought to identify bone marrow-derived mononuclear cell (BM-MNC) subpopulations associated with a combined improvement in left ventricular ejection fraction (LVEF), left ventricular end-systolic volume (LVESV),...
20.
Moye L
Contemp Clin Trials
. 2015 Sep;
45(Pt B):302-310.
PMID: 26390962
The research community has alternatively embraced then repudiated exploratory analyses since the inception of clinical trials in the middle of the twentieth century. After a series of important but ultimately...